(NASDAQ: ASPI) Asp Isotopes's forecast annual revenue growth rate of 92.49% is forecast to beat the US Chemicals industry's average forecast revenue growth rate of 2.27%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.53%.
Asp Isotopes's revenue in 2026 is $30,852,050.On average, 5 Wall Street analysts forecast ASPI's revenue for 2026 to be $3,956,301,860, with the lowest ASPI revenue forecast at $2,689,353,144, and the highest ASPI revenue forecast at $5,795,094,564. On average, 5 Wall Street analysts forecast ASPI's revenue for 2027 to be $10,705,900,624, with the lowest ASPI revenue forecast at $6,896,162,531, and the highest ASPI revenue forecast at $14,453,395,109.
In 2028, ASPI is forecast to generate $37,803,026,920 in revenue, with the lowest revenue forecast at $33,127,090,830 and the highest revenue forecast at $42,336,385,287.